• Science and Research

  Kalydeco Improves Lung Function in CF With Non-Responsive Mutation, Case Study Reports

  Posted by Cystic Fibrosis News Moderator on December 18, 2019 at 9:36 am

  

  Treatment with Kalydeco alone improved lung function and quality of life in a CF patient with responsive and non-responsive mutations, a case study shows. Learn more about this treatment here.

  Have you ever been treated with Kalydeco? How did it affect you?

  Cystic Fibrosis News Moderator replied 5 years ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply